Summary
14 / 100 · Bulios Score
Valuation 50Growth 0Profitability 0Quality 0Debt 17Stability 19
What speaks for it
- It holds more cash than debt: $15.4M against $7.50M.
What to watch
- The company made a loss over the last 12 months.
- It passes only 2 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (AUD)
2022202320242025202620272028
Diluted EPS (AUD)
2022202320242025202620272028
- Analyst estimate
Revenue grew by 31% a year over 5 years.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
YesCash and short-term investments $15.4M
Debt $7.50M
It holds more cash than debt. The debt score is low because of the debt-to-equity ratio (2.2x).
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.